October 1, 2024
ACHP calls on Congress to create a national risk pool for cutting-edge cell and gene therapies to mitigate high costs and ensure the right patients have access at a manageable cost.
New from ACHP:
- ACHP Statement on MAHA Commission
- ACHP Statement on Confirmation of Robert F. Kennedy Jr. as HHS Secretary
- ACHP Letter to CMS on CY 2026 MA and Part D Rate Notice
- ACHP Letter to CMS on Proposed CY 2026 Policy and Technical Changes
- ACHP Letter to National Association of Medicaid Directors
- ACHP Statement on 2027 Medicare Drug Negotiations